News

Oscar Health's profit rebound faces a test as rising medical spending and a larger member base threaten second-half profitability.

Oscar Health (OSCR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

OSCR, SNDR and TFII made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 23rd, 2026.

LCUT, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 23rd, 2026.

Assurant and four other multi-line insurers show improving earnings and operating metrics as higher rates support investment income.

Insurance stocks can be well positioned in a higher interest rate environment, particularly because insurers collect premiums upfront and invest that money until claims are paid.

Oscar Health, Inc. (OSCR) closed the most recent trading day at $31.29, moving 2.61% from the previous trading session.

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 21st, 2026.

Inside the latest chatter from important business leaders.

Oscar Health (NYSE:OSCR) used its Investor Day to unveil the Lucy Healthcare Marketplace, an AI-driven platform for carriers, brokers, and consumers. Management outlined a plan to double earnings per share by 2027, describing it as a core pillar of Oscar Health's next phase. CEO statements at the event argued that traditional employer-sponsored health insurance is ending, and Oscar Health aims to focus on individual coverage. The Lucy Healthcare Marketplace launch and Oscar Health's shift...

Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Oscar Health CFO Scott Blackley joins Ashley Mastronardi on NYSE Floor Talk

Oscar Health CFO joins Ashley Mastronardi on NYSE Live to discuss Takeaways from Company’s Investor Day Event

Oscar Health's (OSCR) target of reaching over $4 of earnings per share by 2029 is "predicated on fai

Oscar Health (OSCR) CEO Mark Bertolini sits down with Yahoo Finance Executive Editor Brian Sozzi to discuss the state of the healthcare industry, highlighting why employer-sponsored health insurance might not last forever.

WOOF, ARW and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 17th, 2026.

Centene's diversified market presence, cash generation and recent share gains give it an edge over Oscar Health as ACA insurers target long-term growth.

Oscar Health raised its full-year earnings outlook while lowering its expected medical costs to cover benefits for its nearly 3 million Affordable Care Act exchange members. Oscar, which made an aggressive play to gain ACA market share, has seen enrollment surge 47% from a year ago as of June 30, even as overall enrollment has plunged due to the expiration of enhanced premium subsidies. The ACA's No. 2 insurer by membership behind Centene said that it now expects its medical loss ratio, or benefit costs as a share of premiums, to be in the 81% to 82% range, down from the prior outlook of 81.5% to 82.5%.

Oscar Health, Inc. (OSCR) closed at $32.62 in the latest trading session, marking a -3.53% move from the prior day.

VLO, SNDR and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 15th, 2026.

Here is how Oscar Health, Inc. (OSCR) and Amerant Bancorp Inc. (AMTB) have performed compared to their sector so far this year.

Apple, which just unveiled its first foldable iPhone and two other new models that go on sale this week, and Taiwan Semiconductor Manufacturing, which makes the chips that power them, lead this weekend's watch list of five top stocks near buy points. Joining AAPL and TSM are cloud-based communications software platform Twilio and two healthcare plays. Oscar Health is the No. 2 health insurer based on Affordable Care Act exchange membership.

A number of stocks jumped in the morning session after Morningstar reported that challenging macroeconomic conditions across broader equity markets drove a rotation into healthcare, lifting the sector index by approximately 7% quarter-to-date to reach a 5% valuation premium.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

A Federal Reserve rate hike is likely while the crypto Clarity Act faces long odds with a Senate vote on deck. Salesforce holds its Dreamforce conference.

CVS Health noted a continuation of "high-trend" medical cost growth at a Wells Fargo investor conference on Wednesday, helping to put a spring in the step of hospital stocks including HCA Healthcare, while souring the mood of managed care investors. Shares of CVS stock came away relatively unscathed, while UnitedHealth slipped and Oscar Health stumbled. CVS management's comments about medical cost trends were brief and vague, while Wells Fargo conference presentations by HCA and Universal Health Services didn't appear to provide updates to Q3 trends since Q2 earnings calls.

Oscar Health (OSCR) exhibits strong technical momentum, recently setting a new all-time high. The stock is up more than 55% over the past year. OSCR’s fundamentals are robust. Revenue is projected to grow 60.17% this year, with earnings estimated to rise 203.58%. Analyst sentiment is broadly positive, with multiple “Strong...

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?

BMA, ATI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 4, 2026.